MDL nieuws
- Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs
- Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B – Reply to Wu et al
- AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia
- Post-ERCP pneumobilia: the risk of cholangitis and recurrent choledocholithiasis
- Response
- Let’s cut to the “core” of the issue!
- Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy
- The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells
- Increases and decreases in liver stiffness measurements are independently associated with the risk of liver-related events in NAFLD
- A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH
- Enhancing the understanding of the risk of incident fracture in entecavir- and TDF-treated elderly patients with chronic hepatitis B (CHB)
- Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74?years (Mamm'OC NCT05067374)
- 89bio initiates phase 3 ENLIGHTEN?Cirrhosis trial of pegozafermin in MASH patients with compensated cirrhosis
- Watch the EASL Studio, your weekly hepatology broadcast!
- Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes